Cleared Traditional

K963002 - ACTIVE ANDROSTENEDIONE EIA

K963002 is the FDA 510(k) clearance for ACTIVE ANDROSTENEDIONE EIA by Diagnostic Systems Laboratories, Inc.. It is a Class 1 Chemistry device (product code CIZ) cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K963002 · Diagnostic Systems Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
14d
Days
Class 1
Risk

K963002 is an FDA 510(k) clearance for the ACTIVE ANDROSTENEDIONE EIA. Classified as Radioimmunoassay, Androstenedione (product code CIZ), Class I - General Controls.

Submitted by Diagnostic Systems Laboratories, Inc. (Webster, US). The FDA issued a Cleared decision on August 16, 1996 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1075 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Systems Laboratories, Inc. devices

Submission Details

510(k) Number K963002 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 02, 1996
Decision Date August 16, 1996
Days to Decision 14 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d faster than avg
Panel avg: 88d · This submission: 14d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CIZ Radioimmunoassay, Androstenedione
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1075
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CIZ Radioimmunoassay, Androstenedione

Devices cleared under the same product code (CIZ) and FDA review panel - the closest regulatory comparables to K963002.
COAT-A-COUNT DIRECT ANDROSTENEDIONE
K954755 · Diagnostic Products Corp. · Nov 1995
ACTIVE ANDROSTANEDIOL GLUCURONIDE
K934751 · Diagnostic Systems Laboratories, Inc. · Jan 1994
DSL ANDROSTENEDIONE RIA (DSL # 4200)
K854673 · Diagnostic Systems Laboratories, Inc. · Jan 1986
DSL ACTIVE ANDROSTENEDIONE RIA (DSL #3800)
K854650 · Diagnostic Systems Laboratories, Inc. · Dec 1985
COAT-A-COUNT ANDROSTENEDIONE RIA KIT
K844398 · Diagnostic Products Corp. · Dec 1984